The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Feb. 08, 2024
Applicant:

Rnaimmune, Inc., Gaithersburg, MD (US);

Inventors:

Neeti Ananthaswamy, Gaithersburg, MD (US);

Yong-Sik Bong, Gaithersburg, MD (US);

David Brown, Gaithersburg, MD (US);

Renxiang Chen, Gaithersburg, MD (US);

Ju Hyeong Jeon, Gaithersburg, MD (US);

Zhifeng Long, Gaithersburg, MD (US);

Dong Shen, Baltimore, MD (US);

Chun Lu, Montreal, CA;

Patrick Y. Lu, Potomac, MD (US);

Shenggao Tang, Guangzhou, CN;

Jiaxi He, Guangzhou, CN;

Ziyang He, Potomac, MD (US);

Assignee:

RNAIMMUNE, INC., Gaithersburg, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/215 (2005.12); A61K 9/1271 (2024.12); A61P 37/04 (2005.12); C07K 14/005 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
A61K 39/215 (2012.12); A61K 9/1271 (2012.12); A61P 37/04 (2017.12); C07K 14/005 (2012.12); A61K 2039/53 (2012.12); C12N 2770/18022 (2012.12); C12N 2770/18034 (2012.12);
Abstract

Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment thereof of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) comprising at least one non-naturally occurring amino acid mutation. In some embodiments, the S protein is derived from a delta variant. Additionally provided are relevant polynucleotides, vectors, cells, compositions, kits, production methods and methods of use.


Find Patent Forward Citations

Loading…